Dr. Ania Jastreboff

Hopefully within our lifetime, I'm about your age, so hopefully within our lifetime that will happen.

Right now, we have tested the medications in people who have obesity and who have overweight with all of these different things that you're mentioning, high blood pressure, high cholesterol, all those things that you're predisposed to genetically.

We don't know whether they're safe yet in people to prevent that obesity.

I think, you know, going forward, we may look at that, but right now we don't know.

And this actually brings up a really important point.

These are medicines, so there's a risk versus benefit ratio that we have to think about.

there are side effects like we talked about.

And so these are not weight loss drugs.

They're not quick fixes.

These are medications.

And so we always have to think about the risk versus benefit.

We know right now the benefit of treating patients with obesity to prevent all of these obesity-related diseases is clear.

There are many studies coming out about heart disease, about preventing diabetes, about treating knee osteoarthritis, about obstructive sleep apnea.

All these things are coming out.

We do not yet have studies to look at obesity prevention, but in people who have a high genetic predisposition, like we've heard from you, from Elizabeth, those are things that I think we'll look at in the future.

Great question.

I agree.

Yeah, I mean, this book is about compassion.

It is about hope.

It is about biology, understanding, and freedom.